Seikagaku and Ono Announce Positive Study Results
Seikagaku and Ono Pharmaceutical obtained positive topline results from a Phase III confirmatory study of an HA/NSAID formulation in the treatment of knee OA. Feb 19, 2019
Royal Philips Launches Zenition Mobile C-arm
Royal Philips launched the Zenition mobile C-arm imaging platform, for initial introduction in the U.S., Austria, Germany and Switzerland in 1H19. Feb 18, 2019
FDA Clears Next SIG Medical AdvantageRib System
SIG Medical received FDA 510(k) clearance for its enhanced AdvantageRib system for rib fracture repair. Full U.S. launch will occur within 1Q19. Feb 18, 2019
AxioMed and NanoFUSE Biologics to be Available for Acquisition
KICVentures seeks funding to prepare its portfolio companies, AxioMed and NanoFUSE Biologics, to be acquisition targets. Feb 14, 2019
Carevature Completes 1,000 Procedures with Dreal Technology
Carevature Medical achieved a milestone of 1,000 procedures using the Dreal® decompression platform. Feb 14, 2019
Life Spine Launches SIMPACT SI Joint Fixation Study
Life Spine initiated an outcomes study for SIMPACT® Sacroiliac Joint Fixation. Feb 14, 2019
AAOS Preview: First-Time Exhibitors, New Offerings on the Exhibit Floor
Each year, I invest a few hours studying the AAOS exhibitor list because I'm genuinely interested to know who is participating. Without fail, a few companies will spark my interest because they're new to me, or because I don't recall having dug into what they do. Here are 10 companies that have never exhibited at AAOS before... perhaps they are your newest competitor, acquisition target, provider or customer. Feb 14, 2019
Flower Orthopedics Grows Ready-for-Surgery Portfolio
Flower Orthopedics launched the Flower Jones Screw and a 6.5mm Headless Compression Screw, additions to its Ready-for-Surgery product line. Feb 13, 2019
Integra LifeSciences Launches Panta 2 TTC Arthrodesis Nail
Integra LifeSciences introduced the Panta® 2 TTC Arthrodesis Nail for tibio-talo-calcaneal fusion. Feb 13, 2019
Intrinsic Therapeutics Receives PMA for Barricaid Annular Closure Device
Intrinsic Therapeutics gained FDA Premarket Approval for the Barricaid annular closure device. Feb 13, 2019
